Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

Lawyers representing OxyContin maker Purdue Pharma, branches of the Sackler family that own it, cities, states, counties, Native American tribes, people with addiction and others across the U.S.

Add Yahoo as a preferred source to see more of our stories on Google. Purdue Pharma and its principal owners the Sackler family have agreed to pay a $7.4 billion settlement to end federal court claims ...

The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma boosted ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut-based ...

OxyContin maker Purdue Pharma ’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it. A judge on Wednesday said he ...

RICHMOND, Va. (WRIC) — Richmond advocates are celebrating the monumental opioid settlement reached with OxyContin maker Purdue Pharma on Friday. On Friday, Nov. 14, a federal bankruptcy court judge ...

Purdue Pharma submitted a bankruptcy restructuring plan March 15 that requires members of the Sackler family to give up control of the company and transforms the Oxycontin-maker into a corporation ...